Q32 Bio (QTTB) Cash from Investing Activities Growth (1y) (2018 - 2025)
Q32 Bio (QTTB) Cash from Investing Activities Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 62.68% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -674.01% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -166.24% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Q32 Bio | 215.94 Mn | 165.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 350,100.00% |
| Sep 30, 2024 | 994,300.00% |
| Jun 30, 2024 | 988,700.00% |
| Mar 31, 2024 | 2,040.00% |
| Sep 30, 2023 | 100.00% |
| Jun 30, 2023 | 100.00% |
| Mar 31, 2023 | -100.00% |
| Dec 31, 2022 | -58.79% |
| Sep 30, 2022 | -2,492.09% |
| Jun 30, 2022 | -201.13% |
| Mar 31, 2022 | 297.47% |
| Dec 31, 2021 | 4,671.83% |
| Sep 30, 2021 | -88.35% |
| Jun 30, 2021 | -126.41% |
| Mar 31, 2021 | -174.12% |
| Dec 31, 2020 | 95.23% |
| Sep 30, 2020 | 395.68% |
| Jun 30, 2020 | 235.79% |
| Mar 31, 2020 | 484.72% |
| Dec 31, 2019 | -296.30% |